On January 3, 2024, the Company’s Extraordinary Shareholders’ Meeting made changes to the Company’s Management Board. As of January 4, 2024, Mr. Ireneusz Fąfara was dismissed from the position of the President of the Company’s Management Board, and the function of the President of the Management Board was entrusted to the Company’s current Vice-President of the Management Board (and its former President), Mr. Paweł Wiśniewski. As of January 4, 2024, the Company’s Management Board has been functioning in a single-member composition – the function of the President of the Management Board is held by Mr. Paweł Wiśniewski.
4Cell Therapies -